CAR-T（CAR-T）细胞疗法在非肿瘤性疾病中的应用
Chimeric antigen receptor T (CAR-T) cell therapy in non-oncological diseases.
CAR-T（CAR-T）细胞在血液系统恶性肿瘤中的应用推动了这种免疫治疗形式的显著进展。
CELL INTELLIGENCE · 肿瘤细胞治疗研究
肿瘤细胞治疗研究
通过单细胞测序检测正常细胞中嵌合抗原受体治疗靶点的表达可能促成脱靶毒性
英文原题：Expression of chimeric antigen receptor therapy targets detected by single-cell sequencing of normal cells may contribute to off-tumor toxicity.
查看英文原题
Expression of chimeric antigen receptor therapy targets detected by single-cell sequencing of normal cells may contribute to off-tumor toxicity.
分数与星级只用于站内排序 —— 不代表疗效、安全性或个人适用性。
摘要
这条来源本身就没有摘要（PubMed 未提供），不是「还没翻译」。可以点最下面的「在 PubMed 查看」打开原文献页面。
论文信息
- 作者
- Jing Y、Liu Y、Li Q、Ye Y、Diao L、Huang Y、Zhou Y、Green MR
- 第一作者单位
- Clinical Research Institute, Shanghai Jiao Tong University School of Medicine, Shanghai, China. Electronic address: yingjing@sjtu.edu.cn.China
- 通讯作者单位
- Center for Epigenetics and Disease Prevention, Institute of Biosciences and Technology, Texas A&M University, Houston, TX, USA; Department of Translational Medical Sciences, College of Medicine, Texas A&M University, Houston, TX, USA; Department of Biochemistry and Molecular Biology, The University of Texas Health Science Center at Houston McGovern Medical School, Houston, TX, USA. Electronic address: leng.han@tamu.edu.United States
- 文献类型
- 读者来信 · 美国 NIH 资助研究 · 非美国政府资助研究
- 期刊
- Cancer cell2021 Dec 13
- 原文标识
- PubMed 34678153 · DOI 10.1016/j.ccell.2021.09.016